Cargando…

Resistance to ibritumomab in lymphoma

Detalles Bibliográficos
Autor principal: Kumar, Lalit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371063/
http://dx.doi.org/10.4103/ijmr.IJMR_1301_19
_version_ 1783561076103708672
author Kumar, Lalit
author_facet Kumar, Lalit
author_sort Kumar, Lalit
collection PubMed
description
format Online
Article
Text
id pubmed-7371063
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-73710632020-07-30 Resistance to ibritumomab in lymphoma Kumar, Lalit Indian J Med Res Book Reviews Wolters Kluwer - Medknow 2020-04 /pmc/articles/PMC7371063/ http://dx.doi.org/10.4103/ijmr.IJMR_1301_19 Text en Copyright: © 2020 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Book Reviews
Kumar, Lalit
Resistance to ibritumomab in lymphoma
title Resistance to ibritumomab in lymphoma
title_full Resistance to ibritumomab in lymphoma
title_fullStr Resistance to ibritumomab in lymphoma
title_full_unstemmed Resistance to ibritumomab in lymphoma
title_short Resistance to ibritumomab in lymphoma
title_sort resistance to ibritumomab in lymphoma
topic Book Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371063/
http://dx.doi.org/10.4103/ijmr.IJMR_1301_19
work_keys_str_mv AT kumarlalit resistancetoibritumomabinlymphoma